Search - tctmd.com

Displaying 41 - 50 of 50

Sort: Relevancy | Date

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

Presentation TCT 2013

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

Presenter: Shamir Mehta

October 30, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

Presentation TCT 2012

STEMI Cocktails

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Clopidogrel Is Still the Choice for Most!

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Believe the Data! Radial Approach for Primary PCI Is Preferred!

Presenter: Shamir Mehta

October 23, 2012

News Daily News

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Caitlin E. Cox

September 28, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

Video

» Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

September 18, 2022

Advertisement

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

STEMI Cocktails

Clopidogrel Is Still the Choice for Most!

Believe the Data! Radial Approach for Primary PCI Is Preferred!

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content